Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome

Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome — Trials · CancerIndex

Clinical trials

Registered studies

72 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 19
Recruiting: 6
Ph III recruiting: 0
Growth YoY: —
Industry share: 5%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (15)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04679194	Study of Mana 312 (Multi Tumor-Associated Antigen T Cells) in Adults With AML/MDS After HSCT	terminated	Phase 1	11	Mana TherapeuticsINDUSTRY	1	Jun 18, 2023	clinicaltrials
NCT00589316	Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome	terminated	Phase 1	26	Fred Hutchinson Cancer CenterOTHER	1